EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals

Alexander A Cohen, Jennifer R Keeffe, Ariën Schiepers, Sandra E Dross, Allison J Greaney, Annie V Rorick, Han Gao, Priyanthi N P Gnanapragasam, Chengcheng Fan, Anthony P West, Arlene I Ramsingh, Jesse H Erasmus und 14 weitere

Cell · 2024-10 · 187 (20) · 5554-5571.e19

DOI: 10.1016/j.cell.2024.07.052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2024-10. Verfasst von Alexander A Cohen und 25 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA. Hauptthemen laut MEDLINE: Antibodies, Viral, COVID-19, COVID-19 Vaccines, Cross Reactions. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Gates Foundation, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralCOVID-19COVID-19 VaccinesCross ReactionsNanoparticlesSpike Glycoprotein, CoronavirusAnimalsFemaleHumansMiceAntibodies, NeutralizingB-LymphocytesMice, Inbred BALB CSARS-CoV-2VaccinationSevere acute respiratory syndrome-related coronavirus

Stichwörter der Autor:innen

RBDSARS-CoV-2antibodyimmune imprintingmacaque and mouse modelsmosaic-8b RBD nanoparticleoriginal antigenic sinprimary addictionsarbecovirusvaccination

Substanzen

Antibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
  • Laboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY 10065, USA.
  • Department of Microbiology, University of Washington, Seattle, WA 98195, USA; National Primate Research Center, Seattle, WA 98121, USA.
  • Medical Scientist Training Program, University of Washington, Seattle, WA 98195, USA.
  • Creative BioSolutions, LLC, Miami, FL 33131, USA.
  • HDT Bio, Seattle, WA 98109, USA.

Förderung

  • NIAID NIH HHS
  • Gates Foundation
  • NIH HHS
  • Wellcome Trust
  • Pfizer
  • Merkin Institute for Translational Research, California Institute of Technology
  • National Institutes of Health
  • Rockefeller University

Zitieren

APA

Cohen, A. A., Keeffe, J. R., Schiepers, A., Dross, S. E., Greaney, A. J., Rorick, A. V., Gao, H., Gnanapragasam, P. N. P., Fan, C., West, A. P., Ramsingh, A. I., Erasmus, J. H., Pata, J. D., Muramatsu, H., Pardi, N., Lin, P. J. C., Baxter, S., Cruz, R., Quintanar-Audelo, M., …, & Bjorkman, P. J. (2024). Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals. Cell, 187(20), 5554-5571.e19. https://doi.org/10.1016/j.cell.2024.07.052

Vancouver

Cohen AA, Keeffe JR, Schiepers A, Dross SE, Greaney AJ, Rorick AV, et al. Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals. Cell. 2024;187(20):5554-5571.e19. doi:10.1016/j.cell.2024.07.052

BibTeX
@article{Cohen2024,
  author = {Cohen, Alexander A and Keeffe, Jennifer R and Schiepers, Ariën and Dross, Sandra E and Greaney, Allison J and Rorick, Annie V and Gao, Han and Gnanapragasam, Priyanthi N P and Fan, Chengcheng and West, Anthony P and Ramsingh, Arlene I and Erasmus, Jesse H and Pata, Janice D and Muramatsu, Hiromi and Pardi, Norbert and Lin, Paulo J C and Baxter, Scott and Cruz, Rita and Quintanar-Audelo, Martina and Robb, Ellis and Serrano-Amatriain, Cristina and Magneschi, Leonardo and Fotheringham, Ian G and Fuller, Deborah H and Victora, Gabriel D and Bjorkman, Pamela J},
  title = {Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals},
  journal = {Cell},
  year = {2024},
  volume = {187},
  number = {20},
  pages = {5554--5571.e19},
  doi = {10.1016/j.cell.2024.07.052}
}
Kostenlos starten →